Spine Matrix is a healthcare company dedicated to the development of medical-grade collagen products. With a focus on cell regeneration, we aim to improve physical health and contribute to societal well-being. Our flagship product is the 3D Spine Matrix Biotechnology, a groundbreaking biological nucleus pulposus implant made from highly compressed collagen.

This implant offers a solution for the 1. 4 million individuals in the EU and USA who undergo nucleotomy due to disc prolapse every year. Our implant allows for an easy surgery, providing patients with a pain-free life and restoring their ability to pursue their professions, hobbies, and overall quality of life.

Established in March 2016, our company is headquartered in Krems, Austria, and operates out of the Technology and Research Center. Our patented collagen matrix is the cornerstone of our technology, offering remarkable biocompatibility and regenerative properties. We also leverage the potential of 3D-bioprinting technology to revolutionize production processes and develop personalized medicine applications.

Our commitment extends to supporting R&D departments, tissue banks, and the pharmaceutical industry with cruelty-free test kits and medical-grade collagen. At Spine Matrix, we are driven by a vision to lead in the biological treatment of herniated spinal discs and to provide exceptional extracellular matrices